The Company has stock-based compensation plans, which are more fully described in Note 12, Stock-Based Compensation, to the Consolidated Financial Statements included in the 2025 10-K. During the three months ended March 31, 2026, the Company granted restricted stock units (“RSUs”) subject to service conditions, RSUs subject to service and performance conditions, and RSUs subject to service and market conditions.

The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the three months ended March 31, 2026:


	Number of Options Outstanding	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value(1)
Outstanding as of December 31, 2025(2)	7,958	$	13.08	3.20 years	$	424
Granted	—	$	—
Exercised	(10)	$	2.68
Forfeited or expired(3)	(35)	$	5.90
Outstanding as of March 31, 2026(2)	7,913	$	13.12	2.95 years	$	—
Exercisable as of March 31, 2026(4)	7,887	$	13.15	2.93 years	$	—
Vested and expected to vest as of March 31, 2026(5)	7,913	$	13.12	2.95 years	$	—

(1)The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.

(2)Includes 3,528 and 3,530 performance condition stock options as of March 31, 2026 and December 31, 2025, respectively.

There were no stock options granted during the three months ended March 31, 2026 and 2025. The total intrinsic value of stock options exercised during the three months ended March 31, 2026 and 2025 was immaterial.

As of March 31, 2026, the total unrecognized compensation cost related to all nonvested stock options was $96 and the related weighted-average period over which it is expected to be recognized was approximately 0.98 years.

The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the three months ended March 31, 2026:


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2025(1)	2,316	$	3.69
Granted(2)	1,302	$	3.36
Vested	(378)	$	4.96
Forfeited(3)	(230)	$	3.36
Outstanding as of March 31, 2026(1)	3,010	$	3.42

(1)Includes 742 and 323 performance condition RSUs as of March 31, 2026 and December 31, 2025, respectively.

The total vesting date fair value of RSUs which vested during the three months ended March 31, 2026 and 2025 was $837 and $729, respectively.

As of March 31, 2026, the total unrecognized compensation cost related to all nonvested RSUs was $7,536 and the related weighted-average period over which it is expected to be recognized was approximately 1.98 years.


	Three Months Ended
	March 31, 2026		March 31, 2025
Stock options	$	—	$	334
Restricted stock units	789		1,026
Employee stock purchase plan	402		383
Total stock-based compensation expense	$	1,191	$	1,743

The following table provides information about stock-based compensation expense by financial statement line item:


	Three Months Ended
	March 31, 2026		March 31, 2025
Cost of revenue (exclusive of depreciation and amortization)	$	—	$	—
Sales and marketing	217		264
Research and development	255		318
General and administrative	719		1,161
Total stock-based compensation expense	$	1,191	$	1,743

Stock-based compensation expense capitalized as part of internal-use software was $46 and $57 for the three months ended March 31, 2026 and 2025, respectively.